Tarceva-7631hkg.7z Instant

The Tarceva brand name has been discontinued in the U.S. in favor of generic alternatives, though the medication (erlotinib) remains in use. Primary Uses

While effective, Tarceva can cause significant side effects that require monitoring: Erlotinib (Tarceva) - Cancer Research UK Tarceva-7631HKG.7z

It is used for locally advanced or metastatic NSCLC that has specific EGFR exon 19 deletions or exon 21 (L858R) substitution mutations. It is used for both first-line treatment and as maintenance therapy after previous chemotherapy. The Tarceva brand name has been discontinued in the U

Tarceva is a targeted therapy drug, specifically an EGFR inhibitor (Epidermal Growth Factor Receptor tyrosine kinase inhibitor). Tarceva-7631HKG.7z